Apolipoprotein A-II (
apoA-II) is the second most abundant
protein in HDLs. Genetic studies in humans have provided evidence of linkage of the
apoA-II gene locus to plasma
free fatty acid (FFA) levels and to
type 2 diabetes, and transgenic mice overexpressing mouse
apoA-II have elevated levels of both FFA and
triglycerides. We now show that
apoA-II promotes
insulin resistance and has diverse effects on fat homeostasis.
ApoA-II transgenic mice have increased adipose mass and higher plasma
leptin levels than C57BL/6J control mice. Fasting
glucose levels were similar between
apoA-II transgenic and control mice, but plasma
insulin levels were elevated approximately twofold in the
apoA-II transgenic mice. Compared with control mice,
apoA-II transgenic mice exhibited a delay in plasma clearance of a
glucose bolus. Adipose tissue isolated from fasted
apoA-II transgenic mice exhibited a 50% decrease in
triglyceride hydrolysis compared with adipose tissue from control mice. This is consistent with a normal response of adipose tissue to the increased
insulin levels in the
apoA-II transgenic mice and may partially explain the increased fat deposition. Skeletal muscle isolated from fasted
apoA-II transgenic mice exhibited reduced uptake of
2-deoxyglucose compared with muscles isolated from control mice. Our observations indicate that a primary disturbance in
lipoprotein metabolism can result in several traits associated with
insulin resistance, consistent with the hypothesis that
insulin resistance and
type 2 diabetes can, under certain circumstances, be related primarily to altered lipid metabolism rather than
glucose metabolism.